美国青少年男孩和女孩人乳头瘤病毒疫苗接种覆盖率:2016-2022年国家免疫调查-青少年出生年份队列分析
该研究利用2016-2022年国家免疫调查-青少年数据,对1999-2009年出生的131,553条记录进行出生队列分析。结果显示,13岁前接种至少1剂HPV疫苗的比例从1999年出生队列的27.0%升至2009年出生队列的69.8%,但总体仍不理想,未接种青少年中82.5%至少错过一次接种机会。
要点
- 13岁前启动HPV疫苗接种比例从1999年出生队列27.0%升至2009年出生队列69.8%。
- 13岁前完成HPV疫苗系列接种比例从1999年出生队列10.3%升至2009年出生队列42.2%。
- 未接种HPV疫苗的青少年中82.5%至少错过一次接种机会,若不错过潜在覆盖率可达94.8%。
核心结论
- 1999-2009年出生青少年中至少1剂HPV疫苗接种覆盖率随出生队列增加,但仍不理想,尤其是未参保青少年。
- 通过有效实施和接种策略以及在同一次就诊中接种所有推荐疫苗,可能减少错过的接种机会。
研究设计与样本
- 出生队列分析,使用2016-2022年国家免疫调查-青少年(NIS-Teen)数据,纳入1999-2009年出生的131,553条记录。
- NIS-Teen为随机数字拨号家庭电话调查,并包括来自接种提供者的疫苗接种数据。
主要发现
- 13岁前接种至少1剂HPV疫苗的比例从1999年出生队列的27.0%上升至2009年出生队列的69.8%。
- 至少1剂HPV疫苗的累积接种比例从13岁前的51.3%上升至17岁时的74.9%。
- 在11-12岁有预防性就诊和拥有保险与更高的至少1剂HPV疫苗接种覆盖率相关。
- 在38,568名(29.3%)未接种HPV疫苗的青少年中,31,513名(82.5%)至少错过一次HPV疫苗接种机会。
- 若不错过接种机会,潜在可达覆盖率为94.8%;13岁前完成HPV疫苗系列接种的比例从1999年出生队列的10.3%上升至2009年出生队列的42.2%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate human papillomavirus (HPV) vaccination coverage among adolescents in the U.S. using birth cohort analysis. METHODS: We conducted a birth cohort analysis among adolescents born during 1999-2009 using National Immunization Survey-Teen (NIS-Teen), a random-digit dialed household telephone survey that also includes vaccination data from providers. We analyzed 131,553 records from 2016 to 2022 NIS-Teen data to determine: trends in coverage with ≥1 HPV vaccine dose before age 13 years and cumulative coverage from age 13-17 years; sociodemographic factors associated with HPV vaccination before age 13 years; missed HPV vaccination opportunities and the potential achievable coverage if opportunities were not missed; and trends in completion of HPV vaccination series. Regression analysis and Kaplan-Meier method provided the average percentage increase in coverage, and cumulative coverage from age 13-17 years stratified by birth cohorts, respectively. RESULTS: HPV vaccination initiation before age 13 years increased from 27.0 % among adolescents born in 1999 to 69.8 % among those born in 2009. Overall, cumulative percent with ≥1 HPV vaccine dose increased from 51.3 % before age 13 years to 74.9 % through age 17 years. Having a preventive visit at ages 11-12 years and being insured were associated with higher ≥1 HPV vaccine dose coverage. Among the 38,568 (29.3 %) adolescents unvaccinated for HPV, 31,513 (82.5 %) missed ≥1 HPV vaccination opportunity. The potential achievable coverage if opportunities were not missed was 94.8 %. Completion of HPV vaccination series before age 13 years increased from 10.3 % among adolescents born in 1999 to 42.2 % among those born in 2009. CONCLUSIONS: Coverage with ≥1 HPV vaccine dose increased by birth cohort among adolescents born 1999-2009 but remained suboptimal, especially among uninsured adolescents. Missed opportunities may be reduced by effective HPV vaccination implementation and uptake strategies and by administering all recommended vaccines during the same visit.
引用
- Nyika P, Yankey D, Elam-Evans LD, et al. Human papillomavirus vaccination coverage among adolescent boys and girls in the United States: A birth year cohort analysis of the National Immunization Survey-Teen, 2016-2022. Vaccine. 2024. PMID: 39615345. doi:10.1016/j.vaccine.2024.126560
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。